Summary:
NAL and MedRx have integrated the next-generation NAL-NL3 fitting formula into MedRx Studio Software v1.3.2 to give hearing care professionals access to more precise evidence-based fitting tools.

Key Takeaways:

  • MedRx is among the first globally to implement NAL-NL3, supporting it across REM/LSM and HIT workflows.
  • Clinicians can now verify and fine-tune fittings using real-ear and HIT measurements aligned to NAL-NL3 targets.
  • The integration highlights the impact of research–industry collaboration in accelerating innovative tools for better hearing outcomes.

National Acoustic Laboratories (NAL) and MedRx have worked together to bring the next-generation NAL-NL3 fitting formula to MedRx’s verification and testing systems. This integration—now available in MedRx Studio Software version 1.3.2—marks one of the first implementations of NAL-NL3 worldwide, made possible through the longstanding collaboration between NAL, MedRx, and the broader Demant Group. This new software version enables hearing care professionals to deliver more precise, personalized fittings, according to the company. 

Key Highlights of the Integration

  • NAL-NL3 is the latest evidence-based fitting system designed to optimize speech intelligibility and listening comfort.
  • MedRx Studio v1.3.2 now supports NAL-NL3 across REM/LSM and HIT workflows.
  • Compatible with MedRx AVANT HIT+, AVANT REM+, AVANT ARC, WREM, and AWRC systems.
  • Clinicians can verify fittings using real-ear measurements and confirm device performance in the HIT box—all aligned to NAL-NL3 targets.
  • This release underscores how research and industry collaboration can translate into faster access to evidence-based tools for hearing care professionals worldwide.

“This makes MedRx the first verification systems globally to integrate and offer the NAL-NL3 Fitting System, including the two new modules for special use cases,” says Brent Edwards, PhD, director of the National Acoustic Laboratories. “Clinicians now have access to the most advanced fitting formula available today, helping them deliver even better outcomes for people with hearing difficulties.”

“MedRx is committed to delivering cutting-edge tools for hearing care professionals,” adds Caleb Sparkman, president of MedRx. “Integrating NAL-NL3 into our software reflects our dedication to best practices and innovation.” 

Clinicians can access NAL-NL3 by updating to MedRx Studio Software v1.3.2.

For more information, visit nal-nl3.com.au and https://www.medrx-diagnostics.com. 

Featured image: MedRx